Il s'agit de notre dernière sélection de publications et de brevets mondiaux en anglais sur la biotechnologie et CRISPR, parmi de nombreuses revues scientifiques en ligne, classées et axées sur CRISPR, l'édition de gènes, l'ARNg, la séquence PAM, le clivage de l'ADN, la protéine Cas9, l'édition du génome, l'insertion de gènes et le knock-out de gènes.
Publication: pas de nouvelles récentes sur ce sujet particulier. Veuillez essayer la recherche manuelle approfondie dans la base de données des publications dont le lien figure juste au-dessus.
Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a
Patent published on the 2025-05-21 in EP under Ref EP4556567 by FELDAN BIO INC [CA] (Del'guidice Thomas [ca], Lepetit-stoffaes Jean-pascal [ca], Guay David [ca])
Abstract: The present description relates to methods for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell. The methods involve contacting the cell with the polypeptide cargo in the presence of a peptide shuttle agent at a concentration sufficient to increase the polypeptide cargo's transduction efficiency. Also described here are parameters that may be used in the rational design of such synthetic peptide shuttle agents, peptide shuttle ag[...]
Our summary: Methods for delivering polypeptide cargos using synthetic peptide shuttle agents to increase transduction efficiency in target eukaryotic cells. Parameters for rational design, shuttle agents satisfying design parameters, and compositions for delivering various polypeptide cargos are also discussed. Applications and targets for genome-editing NK cells for improved immunotherapy are included.
synthetic peptide, shuttle agents, polypeptide cargos, transduction efficiency
Patent
Genome editing of plant jaz genes for pathogen resistance and improved fiber quality and yield
Patent published on the 2025-03-06 in WO under Ref WO2025050099 by TEXAS TECH UNIV SYSTEM [US] (Rock Chris [us], Sukumaran Sunitha [us])
Abstract: Embodiments of the present disclosure pertain to a plant or seed that includes one or more altered JASMONATE-ZIM DOMAIN repressor (JAZ) genes. Additional embodiments of the present disclosure pertain to methods of altering one or more JAZ genes of a plant or seed by introducing one or more alterations to the one or more JAZ genes of the plant or seed. The altered plants and seeds of the present disclosure may exhibit one or more altered properties, such as jasmonic acid (JA) insensitivity, enhan[...]
Our summary: Genome editing of plant JAZ genes for pathogen resistance and improved fiber quality and yield. Altered plants and seeds with enhanced resistance to pathogens and insects, and improved fiber yield and quality.
Genome editing, Plant, JAZ genes, Pathogen resistance
Patent
Interesting read, but dont you think the ethical implications of CRISPR should be addressed more thoroughly in these publications?
Interesting read, but shouldnt there be more public debate on ethical implications before CRISPR becomes commonplace? Just food for thought.
Interesting read! But do we have enough ethical guidelines in place to regulate these CRISPR advancements? Just food for thought.
Les commentaires sont fermés.